VanEck Pharmaceutical ETF
PPH
PPH
44 hedge funds and large institutions have $57.7M invested in VanEck Pharmaceutical ETF in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
44
Holders Change
-5
Holders Change %
-10.2%
% of All Funds
0.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
9
Reduced
14
Closed
7
Calls
$2.34M
Puts
$1.65M
Net Calls
+$696K
Net Calls Change
-$156K
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$3.98M |
| 2 |
DI
DFPG Investments
Sandy,
Utah
|
+$581K |
| 3 |
CG
Cutler Group
San Francisco,
California
|
+$81K |
| 4 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$74.3K |
| 5 |
WI
Wintrust Investments
Chicago,
Illinois
|
+$65.3K |
Top Sellers
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$72.7M |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
-$49.2M |
| 3 |
WWM
Western Wealth Management
Golden,
Colorado
|
-$4.45M |
| 4 |
Goldman Sachs
New York
|
-$4.32M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$893K |